More from ASCO 2023 [1]:
“We found in ARCHES that in the men who developed radiographic progression while on ADT-enzalutamide [Xtandi], two thirds of these patients, when they had radiographic progression, did not meet PSA progression criteria, and one third didn't have any rise at all in their PSA,” says Andrew J. Armstrong, MD, MSc."
Imaging becomes important when PSA becomes unreliable.
-Patrick
Apologies - this was from 2022.
I apparently missed it, so thank you!
thanks Patrick. This is a bit concerning because it is often the PSA increase that triggers the imaging at least in the NHS.
The NHS does have a tendency to follow only PSA so you need to insist on a scan every 6 months regardless of PSA. My experience is they will do it if you ask for it.
PSA 2.7, going for scans today.
As relevant today as it was a year ago.
Outcome of the TheraP Trial - So Much More than Overall Survival
ADT vacation versus Continuous
combining standard PCA care with alternative care
